L-glutamine alters HSP levels and normalises energy status in patients with atrial fibrillation
Unraveling of genetic causes of atrial fibrillation: from mechanism to treatment
Inflammasomes and Proteostasis: Novel Molecular Mechanisms Associated With Atrial Fibrillation
Weighing the Effectiveness of Photoplethysmography Signal Analysis in Population Diagnosis of Atrial Fibrillation
Cell-free circulating mitochondrial DNA: a potential blood-based marker for atrial fibrillation
Atrial Fibrillation Finger Printing
DNA Damage in Atrial Fibrillation: a Promising Treatment Target?
The Genetic Puzzle of Familial Atrial Fibrillation
Atrial fibrillation (AF) is the most common progressive tachyarrhythmia. In Europe, AF is expected to reach a prevalence of 18 million by 2060. This estimate will increase hospitalization for AF to 4 million and 120 million outpatient visits. Besides being an independent risk factor for mortality, AF is also associated with an increased risk of […]